As of 2024-12-12, the Relative Valuation of Inari Medical Inc (NARI) is (19.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.21 USD, the upside of Inari Medical Inc based on Relative Valuation is -132.7%.
The range of the Relative Valuation is (35.22) - 5.62 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.2x - 39.2x | 31.8x |
| Forward P/E multiples | 29.6x - 40.4x | 33.6x |
| Fair Price | (35.22) - 5.62 | (19.03) |
| Upside | -160.5% - -90.3% | -132.7% |
| Date | P/E |
| 2024-11-29 | -38.68 |
| 2024-11-27 | -38.02 |
| 2024-11-26 | -37.87 |
| 2024-11-25 | -36.86 |
| 2024-11-22 | -36.99 |
| 2024-11-21 | -37.06 |
| 2024-11-20 | -36.50 |
| 2024-11-19 | -37.97 |
| 2024-11-18 | -38.23 |
| 2024-11-15 | -37.66 |
| 2024-11-14 | -36.68 |
| 2024-11-13 | -37.82 |
| 2024-11-12 | -38.22 |
| 2024-11-11 | -39.74 |
| 2024-11-08 | -38.28 |
| 2024-11-07 | -38.62 |
| 2024-11-06 | -39.68 |
| 2024-11-05 | -37.28 |
| 2024-11-04 | -36.45 |
| 2024-11-01 | -36.31 |
| 2024-10-31 | -36.06 |
| 2024-10-30 | -35.09 |
| 2024-10-29 | -36.64 |
| 2024-10-28 | -31.71 |
| 2024-10-25 | -32.55 |
| 2024-10-24 | -32.75 |
| 2024-10-23 | -32.86 |
| 2024-10-22 | -33.11 |
| 2024-10-21 | -32.68 |
| 2024-10-18 | -32.95 |
| 2024-10-17 | -32.38 |
| 2024-10-16 | -33.08 |
| 2024-10-15 | -33.42 |
| 2024-10-14 | -31.44 |
| 2024-10-11 | -31.14 |
| 2024-10-10 | -30.27 |
| 2024-10-09 | -31.06 |
| 2024-10-08 | -31.59 |
| 2024-10-07 | -30.26 |
| 2024-10-04 | -31.23 |
| 2024-10-03 | -31.00 |
| 2024-10-02 | -31.90 |
| 2024-10-01 | -30.27 |
| 2024-09-30 | -30.72 |
| 2024-09-27 | -30.69 |
| 2024-09-26 | -30.30 |
| 2024-09-25 | -30.90 |
| 2024-09-24 | -31.61 |
| 2024-09-23 | -32.16 |
| 2024-09-20 | -32.54 |